Two Life Science Entrepreneurs Unveil AI’s Future in Clinical Trials

In this episode of our Towards Health podcast, Ariel Katz, Co-Founder and CEO of H1 sat down with Michelle Longmire, Co-Founder and CEO of Medable – a global cloud platform that provides access to patients for clinical research. Both Katz and Longmire have been recognized as leaders in the healthcare technology space and are passionate about moving life sciences forward, including the potential for AI integration.

This conversion dives into how AI can and will transform the clinical trial space. As Longmire explains in the podcast, her goal is to connect patients to the healthcare ecosystem from both a clinical and research perspective, as they are the primary generators of healthcare data and the primary recipients of its value.

Watch the full podcast conversation below to hear the answers to these questions and more:

  • When you started Medable, decentralized trials weren’t as big of a thing; How did you know it would turn into such an industry norm?
  • What are you seeing happening next for the next wave of tech innovations for clinical trials?
  • How are you seeing GenAI and the OpenAI craze affecting your conversations with pharma companies?